Literature DB >> 10382874

Antimicrobial activity and accumulation of moxifloxacin in quinolone-susceptible bacteria.

L J Piddock1, Y F Jin.   

Abstract

The antibacterial activity of moxifloxacin, compared with that of ciprofloxacin, was determined for five strains of Staphylococcus aureus, including one NorA-overproducing strain, two quinolone-susceptible strains of Streptococcus pneumoniae, four quinolone-susceptible strains of Haemophilus influenzae, and one strain each of quinolone-susceptible Escherichia coli, Pseudomonas aeruginosa and Moraxella catarrhalis. In addition, the accumulation of moxifloxacin and ciprofloxacin by the NCTC type strain of S. pneumoniae, H. influenzae, S. aureus, E. coli and P. aeruginosa was determined by a fluorescence method. For all strains, moxifloxacin accumulated to a lower concentration than ciprofloxacin. The concentrations of moxifloxacin accumulated ranged from 12 to 44 ng/mg dry cells. The lowest concentration was accumulated by S. pneumoniae NCTC 7465 and the highest concentration by S. aureus NCTC 8532. Increased expression of norA in S. aureus had no effect on the accumulation of moxifloxacin. Despite differences in the concentration of moxifloxacin accumulated by the different species, there was little difference between the MICs of this agent for each strain (0.06-0.5 mg/L), suggesting that the concentration accumulated by wild-type bacteria has little effect on the MIC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10382874     DOI: 10.1093/jac/43.suppl_2.39

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  6 in total

1.  Evidence of active efflux in resistance to ciprofloxacin and to ethidium bromide by Mycoplasma hominis.

Authors:  S Raherison; P Gonzalez; H Renaudin; A Charron; C Bébéar; C M Bébéar
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

2.  Characterization of the interactions between fluoroquinolone antibiotics and lipids: a multitechnique approach.

Authors:  Hayet Bensikaddour; Nathalie Fa; Ingrid Burton; Magali Deleu; Laurence Lins; André Schanck; Robert Brasseur; Yves F Dufrêne; Erik Goormaghtigh; Marie-Paule Mingeot-Leclercq
Journal:  Biophys J       Date:  2008-01-04       Impact factor: 4.033

3.  Quantitative analysis of gentamicin, azithromycin, telithromycin, ciprofloxacin, moxifloxacin, and oritavancin (LY333328) activities against intracellular Staphylococcus aureus in mouse J774 macrophages.

Authors:  Cristina Seral; Françoise Van Bambeke; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

4.  Activity of and resistance to moxifloxacin in Staphylococcus aureus.

Authors:  Dilek Ince; Xiamei Zhang; David C Hooper
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

5.  Comparative intracellular (THP-1 macrophage) and extracellular activities of beta-lactams, azithromycin, gentamicin, and fluoroquinolones against Listeria monocytogenes at clinically relevant concentrations.

Authors:  Stéphane Carryn; Françoise Van Bambeke; Marie-Paule Mingeot-Leclercq; Paul M Tulkens
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

6.  Uptake of Ozenoxacin and Other Quinolones in Gram-Positive Bacteria.

Authors:  Yuly López; Laura Muñoz; Domingo Gargallo-Viola; Rafael Cantón; Jordi Vila; Ilonka Zsolt
Journal:  Int J Mol Sci       Date:  2021-12-12       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.